Enrichment of cancer stem cell of glioblastoma by neurosphere formation

Tissue Engineering and Regenerative Medicine

Volumn 9, Issue SUPPL. 1, 2012, Pages 40-47

  Moon, Seok Ho ^a   Park, Kyung Soon ^a  

^a CHA University   (South Korea)

Author keywords

Cancer stem cell; Glioblastoma; Neurosphere

Indexed keywords

ANTICANCER DRUG; CANCER RECURRENCE; CANCER STEM CELLS; CELL MIGRATION; CELL SURFACE MARKER; GLIOBLASTOMAS; NEUROSPHERE; PATIENT SURVIVALS;

CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; DISEASES; PLATINUM COMPOUNDS; POPULATION STATISTICS; STEM CELLS;

TUMORS;

EID: 84884633117     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. D Bonnet, JE Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med, 3, 730 (1997).
2. SK Singh, C Hawkins, ID Clarke, et al., Identification of human brain tumour initiating cells, Nature, 432, 396 (2004).
3. E Passegué, CH Jamieson, LE Ailles, et al., Normal and leukemic hematopoiesis : are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?, Proc Natl Acad Sci U S A, 100 Suppl 1, 11842 (2003).
4. S Bao, Q Wu, RE McLendon, et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756 (2006).
5. T Kondo, T Setoguchi, T Taga, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc Natl Acad Sci U S A, 101, 781 (2004).
6. C Hirschmann-Jax, AE Foster, GG Wulf, et al., A distinct " side population" of cells with high drug efflux capacity in human tumor cells, Proc Natl Acad Sci U S A, 101, 14228 (2004).
7. M Locke, M Heywood, S Fawell, Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines, Cancer Res, 65, 8944 (2005).
8. L Patrawala, T Calhoun, R Schneider-Broussard, et al., Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic, Cancer Res, 65, 6207 (2005).
9. N Sanai, A Alvarez-Buylla, MS Berger, Neural stem cells and the origin of gliomas, N Engl J Med, 353, 811 (2005).
10. R Stupp, WP Mason, MJ van den Bent, et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987 (2005).
11. SG Piccirillo, BA Reynolds, N Zanetti, et al., Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, 444, 761 (2006).
12. R Stupp, ME Hegi, Targeting brain-tumor stem cells, Nat Biotechnol, 25, 193 (2007).
13. SK Singh, ID Clarke, M Terasaki, et al., Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821 (2003).
14. D Beier, P Hau, M Proescholdt, et al., CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles, Cancer Res, 67, 4010 (2007).
15. H Ikushima, T Todo, Y Ino, et al., Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sryrelated HMG-box factors, Cell Stem Cell, 5, 504 (2009).
16. J Lu, G Getz, EA Miska, et al., MicroRNA expression profiles classify human cancers, Nature, 435, 834 (2005).
17. VK Gangaraju, H Lin, MicroRNAs: key regulators of stem cells, Nat Rev Mol Cell Biol, 10, 116 (2009).
18. SM Hammond, MicroRNAs as oncogenes, Curr Opin Genet Dev, 16, 4 (2006).
19. J Li, S Liang, H Yu, et al., An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer, Gynecol Oncol, 119, 543 (2010)